The use of molecular profiling for diagnosis and research in non-Hodgkin's lymphoma.

Molecular profiling facilitates the understanding of the genetic processes underlying the development of cancer, and makes it possible to use specific signatures to prognosticate clinical outcome and to predict response to specific treatments. There has been a great increase in the availability of tools for exploring genetic abnormalities in cancer cells, which have allowed a more comprehensive characterization of the mutations, translocations, and copy-number variations that may affect the development of cancer or therapy response. An improved understanding of the molecular basis of cancer is helping also in the identification of new molecular targets for therapy.